奥美拉唑
医学
兰索拉唑
埃索美拉唑
显微镜下结肠炎
胶原性结肠炎
质子抑制剂泵
胃肠病学
结肠炎
淋巴细胞性结肠炎
内科学
组织病理学
活检
腹泻
病理
疾病
炎症性肠病
作者
Gilbert M. Wilcox,Anthony R. Mattia
标识
DOI:10.1097/mcg.0b013e31817d3fa1
摘要
Goals The aim of this study was to determine whether proton pump inhibitors other than lansoprazole might be associated with microscopic colitis. Background Lansoprazole exposure has been associated with diarrhea and microscopic colitis, but this relationship has not been described with other proton pump inhibitors. Study Cases of microscopic colitis from a consultative gastroenterology practice were collected and reviewed for proton pump inhibitor exposure. Standard clinical, endoscopic, and biopsy findings were analyzed. Results A case series of 4 patients is described in which subjects developed classic symptoms of lymphocytic-collagenous colitis with typical mucosal histopathology during treatment with omeprazole/esomeprazole. Symptoms promptly stopped and mucosal biopsies returned to normal with drug withdrawal. Disease quickly recurred in 2 patients who were reexposed to the drugs, one with biopsy documented recurrent collagenous colitis. Conclusions Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure. These results have epidemiologic, diagnostic, and therapeutic ramifications, which are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI